Description
Ultima-HGH Fragment 176-191, 10 mg
Ultima-HGH Fragment 176-191 10 mg contains HGH Fragment 176-191, a synthetic peptide corresponding to the C-terminal portion of human growth hormone. It is primarily researched for lipolysis, fat metabolism, adipose-tissue signaling, and body-composition pathways.
How it works
HGH Fragment 176-191 represents amino acids 176 through 191 of human growth hormone. Research has focused on whether this region can reproduce some of GH’s lipolytic and anti-lipogenic activity without activating the classical growth-promoting GH pathway.
Proper Use and Dosage
The listed presentation contains 10 mg (10,000 mcg) per vial.
For the 10 mg presentation:
100 mcg = 100 portions
250 mcg = 40 portions
500 mcg = 20 portions
1 mg = 10 portions
2 mg = 5 portions
2.5 mg = 4 portions
5 mg = 2 portions
10 mg = 1 full vial
Benefits
Ultima-HGH Fragment 176-191 is particularly relevant to research involving fat metabolism, lipolysis, body composition, and adipose-tissue biology.
Key areas of interest include:
Investigated for lipolysis
Supports research into fat oxidation
Studied for inhibition of lipogenesis
Relevant to adipose-tissue signaling
Investigated for body-composition pathways
Studied in relation to visceral and abdominal fat
Does not represent full-length HGH
Research interest in metabolic pathways without classical GH signaling
Particularly relevant to fat-loss-focused research
Convenient 10 mg presentation
The compound’s main research appeal is its proposed ability to influence fat metabolism without reproducing the complete biological activity of full-length growth hormone. Most evidence supporting these effects remains preclinical.
Side Effects
Because unmodified HGH Fragment 176-191 lacks controlled human clinical studies, its human safety and side-effect profile have not been adequately established. This is an important distinction from AOD-9604, a modified relative that underwent human clinical development.
